glp 1 type 1 diabetes glp-1 shortage guidance New on the use of GLP-1-based drugs in people with (T1D), due to be published later this year, will address PENDULUM The Impact of Expanded Amount:10mg × 4 pens

glp 1 type 1 diabetes glp-1 shortage guidance New on the use of GLP-1-based drugs in people with (T1D), due to be published later this year, will address PENDULUM The Impact of Expanded Amount:10mg × 4 pens

The Impact of Expanded GLP-1 Accessibility on the CPG Landscape | Consumer Goods Technology

Its oral formulation, Rybelsus, was approved in 2019 for type 2 diabetes

PENDULUM

Amount:10mg × 4 pens

The ongoing trends include a growing use of oral formulations of GLP-1 together with long-acting injectables, integration of digital health tools for adherence, and a focused approach to real-world evidence studies that provide long-term outcomes